News
NETRF Works to Take PRRT to Next Level
The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing a precision form of radiation therapy for NETs called Peptide Receptor
Heat-Related Illness in Neuroendocrine Cancer
Summer sun safety tips for cancer survivors. The signs and symptoms of heat-related illness.
NETRF Seed Funding Helps Grow the Field
Two NETRF-funded researchers received Career Development Awards at the 2018 annual meeting of the American Society of Clinical Oncology (ASCO), one of the largest and
What Do I Know for Sure about My Survivorship
by Stacie Chevrier, NET Cancer Blogger Every Sunday on the O Network’s Super Soul Sunday, Oprah asks her guest, “What do you know for sure?” This
Living Well with Serious Illness
Dispelling Myths about Palliative Care The goals of palliative care according to Steven Pantilat, MD, University of California, San Francisco, are pretty straightforward—to do as
NETRF Works to Take PRRT to Next Level
https://www.youtube.com/watch?v=k1906SABias The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing a precision form of radiation therapy for NETs called Peptide Receptor
MD Anderson Scientist Awarded Research Grant
Can an epigenetic enzyme under the right conditions contribute to the growth of cancer cells? If so, what happens if the enzyme is removed? Can
I am a NET Survivor – National Cancer Survivors Day
National Cancer Survivors Day is Sunday, June 3, 2018 Show you are a NET survivor and celebrate life, acknowledge those living with this rare disease,
The Power of Participation
Having arrived seven weeks ago as the new Chief Development Officer, I have been so inspired by the team spirit of NETRF. From our dedicated
Trust Challenges in the NET Patient/Doctor Relationship
After you’ve been told you had food poisoning or were in menopause, but you had cancer….how do you learn to trust your doctor again? NET specialist Pamela Kunz, MD, talks about trust issues between doctors and patietnts.